Data driven polypharmacological drug design for lung cancer: analyses for targeting ALK, MET, and EGFR. (Q42697768)
Jump to navigation
Jump to search
scientific article published on 4 July 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Data driven polypharmacological drug design for lung cancer: analyses for targeting ALK, MET, and EGFR. |
scientific article published on 4 July 2017 |
Statements
Data driven polypharmacological drug design for lung cancer: analyses for targeting ALK, MET, and EGFR (English)
Osman A B S M Gani
Franz X E Gruber
1 reference
1 reference
1 reference
Identifiers
1 reference
28 January 2021
1 reference